Network meta-analysis compares pharmacological and biological therapies for amyotrophic lateral sclerosis
New ALS Therapy Combo Shows Promise For Slowing Functional Decline
This network meta-analysis synthesized data from 109 trials involving 16,353 participants to evaluate pharmacological and biological therapi…
A major analysis suggests combining cell therapy with neuroprotective drugs may help ALS patients maintain physical function longer, though …
Masitinib 4.5 mg/kg/day associated with survival in ALS post-hoc analysis
This Drug Could Add Nearly Two Years to ALS Life
This post-hoc analysis of a randomized, double-blind, placebo-controlled trial in 130 ALS patients found that masitinib 4.5 mg/kg/day was as…
A new look at data suggests a specific drug might significantly extend life for some people with ALS.